Novel Coronavirus; | sciencenewsnet.in

Breaking News

These jacks-of-all-trades are masters, too: Yeast study helps answer age-old biology question

Living with Stage 3 lung cancer in your 80s and 90s

ETRI published Key International Standards for Wearable Healthcare

Study Unveils Balance of AI and Preserving Humanity in Health Care

Press Registration for the ASRS 2024 Annual Scientific Meeting Now Open

A systematic review of three key sugar metabolism proteins, HXK, SnRK1 and TOR, in the regulatory network of plant growth, development and stress

Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards

Potential new worlds rescued by citizens of Earth! Early results of people-powered astronomy project ‘out of this world’

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

BIMM University chooses Figshare to showcase its non-traditional research and creative practitioner outputs

26 Apr, 2024

Epidemiology expert: Strive for diversity in COVID-19 vaccine/drug clinical trials

April 7, 2020 sarah JonasExpert Pitch

As clinical trials on potential vaccines and treatment drugs for the COVID-19 disease caused by the novel coronavirus get underway, researchers should strive for diversity in test subject selection, according to a leading expert on the topic. Marjorie A. Speers,…

How to prepare in the event of a pandemic

February 27, 2020 sarah JonasFeature

UAB experts provide tips for you to prepare yourself in the event of the spread of COVID-19.

Expert analysis by Thunderbird’s Doug Guthrie: The Age of Cooptation: The Cost of Doing Business in Xi’s China

February 27, 2020 sarah JonasExpert Pitch

The Age of Cooptation: The Cost of Doing Business in Xi’s China (Business, China, China Capitalism, International Trade, Supply Chain, Xi Jinping, Covid19, Coronavirus) By Doug Guthrie The cost of doing business in China today is a high one,…